|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $970 and $712 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Current contract assets | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Non-current contract assets | ||||||||||||||||||||
| Deferred income tax asset | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued airtime | ||||||||||||||||||||
| Accrued compensation and employee-related expenses | ||||||||||||||||||||
| Accrued loss on future firm purchase commitments | ||||||||||||||||||||
| Accrued other | ||||||||||||||||||||
| Accrued product warranty costs | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Current operating lease liability | ||||||||||||||||||||
| Liability for uncertain tax positions | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term operating lease liability | ||||||||||||||||||||
| Long-term contract liabilities | ||||||||||||||||||||
| Deferred income tax liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value. Authorized 1,000,000 shares; none issued | ||||||||||||||||||||
| Common stock, $0.01 par value. Authorized 30,000,000 shares; 21,364,212 and 21,294,655 shares issued at June 30, 2026 and December 31, 2025, respectively; and 19,293,315 and 19,511,836 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders equity before treasury stock adjustment | ||||||||||||||||||||
| Less: treasury stock at cost, common stock, 2,070,897 and 1,782,819 shares as of June 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
